There is no government strategy to fight the spread of AIDS in Russia, where the number of deaths caused by the disease continues to grow, a senior healthcare official said on Thursday.
May 16, 2013
0
0
(HealthDay)—There has been a dramatic increase in the number of emergency-room visits related to sleep medications such as Ambien, according to a new U.S. study.
May 1, 2013
0
0
Gilead Sciences Inc. says that the Food and Drug Administration rejected two marketing applications for HIV treatments, citing quality control problems at the company's manufacturing facilities.
Apr 29, 2013
0
0
If you were born during 1945-1965, talk to your doctor about getting tested for hepatitis C. The word "hepatitis" means swelling of the liver. Hepatitis is most often caused by a virus. In the United States, the most common ...
Apr 29, 2013
0
0
In South Africa, people with HIV who start treatment with anti-AIDS drugs (antiretroviral therapy) have life expectancies around 80% of that of the general population provided that they start treatment before their CD4 count ...
Apr 9, 2013
0
0
A new discovery about the malaria-related parasite Toxoplasma gondii—which can threaten babies, AIDS patients, the elderly and others with weakened immune function—may help solve the mystery of how this single-celled ...
Apr 8, 2013
0
0
South Africa's health minister on Monday launched a new single dose anti-AIDs drug which will simplify the world's biggest HIV treatment regime to just one life-saving pill a day.
Apr 8, 2013
0
0
India's Supreme Court is to rule Monday on a landmark patent case involving Swiss drugmaker Novartis AG that focuses on demands by major companies that their investments be protected, against Indian companies that say they ...
Mar 31, 2013
0
0
Results of a study published online in the Journal of Antimicrobial Chemotherapy today (Thursday), demonstrate that computer models can predict how HIV patients whose drug therapy is failing will respond to a new treatment. ...
Mar 13, 2013
0
0
(AP)—A New Jersey-based generic drug maker has agreed to pay $45 million to resolve criminal and civil liability charges for improperly marketing its weight-gain drug to frail seniors.
Mar 5, 2013
0
0
